Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02533843 · ClinicalTrials.gov registry record · Phase 3
Outcome of Different Ablation Strategies In Persistent and Long-Standing Persistent Atrial Fibrillation
A Phase 3 study, sponsored by Texas Cardiac Arrhythmia Research Foundation.
- Completed
- Registry status
- Phase 3
- Development phase
- 120
- Enrollment target
NCT02533843 is a Phase 3 study that has completed, run by Texas Cardiac Arrhythmia Research Foundation. The registered enrollment target is 120 participants.
The verdict
NCT02533843, a Phase 3 study, has completed, sponsored by Texas Cardiac Arrhythmia Research Foundation.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 120 participants
- Enrollment target
Study Summary
Specific Aim: This prospective randomized study aims to compare the impact of three different catheter ablation approaches on long-term procedure outcome in terms of arrhythmia recurrence in persistent (PeAF) and long-standing persistent atrial fibrillation (LSPAF) patients. The three strategies to be evaluated are 1) ablation at sources guided by FIRMap (using RhythmView™ Workstation from TOPERA), 2) ablation at sources guided by FIRMap + conventional pulmonary vein antrum isolation (PVAI) and 3) Extended PVAI plus ablation of non-PV triggers and complex fractionated atrial electrograms (CFAE).
Interventions
- PROCEDURE radiofrequency catheter ablation
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 120 participants |
| Start Date | 2014-04 |
| Est. Completion | 2017-07 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02533843
The ClinicalTrials.gov registry entry for NCT02533843 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 120 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Texas Cardiac Arrhythmia Research Foundation, which has 15 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which radiofrequency catheter ablation is the first listed.
NCT02533843 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02533843 about?
NCT02533843 is a clinical study titled "Outcome of Different Ablation Strategies In Persistent and Long-Standing Persistent Atrial Fibrillation". Specific Aim: This prospective randomized study aims to compare the impact of three different catheter ablation approaches on long-term procedure outcome in terms of arrhythmia recurrence in persistent (PeAF) and long-standing persistent atrial fibrillation (LSPAF) patients. The three strategies to ...
What is the current status of trial NCT02533843?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 120 participants. The study started on 2014-04. Estimated completion is 2017-07.
What interventions are being tested in trial NCT02533843?
The interventions under investigation include: radiofrequency catheter ablation (PROCEDURE).
Who is sponsoring clinical trial NCT02533843?
This trial is sponsored by Texas Cardiac Arrhythmia Research Foundation, which has 15 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.